Anti-PLBD2 Antibody (ABIN7599688). Tested in WB, IHC, ICC/IF, IF, Flow Cytometry, ELISA applications. This antibody reacts with Human. This is a premium antibody that guarantees superior quality, high affinity, and strong signals with minimal background in Western blot applications.
Purification
Immunogen affinity purified.
Immunogen
E.coli-derived human PLBD2 recombinant protein (Position: Q108-Q525). Human PLBD2 shares 88% and 87.1% amino acid (aa) sequence identity with mouse and rat PLBD2, respectively.
Western blot, 0.25-0.5 μg/mL, Human Immunohistochemistry, 2-5 μg/mL, Human Immunocytochemistry/Immunofluorescence, 5 μg/mL, Human Immunofluorescence, 5 μg/mL, Human Flow Cytometry (Fixed), 1-3 μg /1x106 cells, Human ELISA, 0.1-0.5 μg/mL, -
Restrictions
For Research Use only
Format
Lyophilized
Reconstitution
Adding 0.2 mL of distilled water will yield a concentration of 500 μg/mL.
At -20°C for one year from date of receipt. After reconstitution, at 4°C for one month. It can also be aliquotted and stored frozen at -20°C for six months. Avoid repeated freezing and thawing.
Target
PLBD2
(Phospholipase B Domain Containing 2 (PLBD2))
Alternative Name
PLBD2
Background
Putative Phospholipase B-like (PLBD2) is a 585 amino acids lipoprotein lipase (LPL) encoded by the or Plbd2 gene. PLBD2 is considered a difficult-to-remove Host Cell Protein (HCP) from Chinese hamster ovary (CHO) cells derived therapeutic antibodies. Some HCPs could cause immunogenic responses in patients if not removed.